Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 5/20 | 0.43 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.43 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.39 |
| ▸ | TERT | O14746 | 3/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | BLM | P54132 | 2/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.38 |
| ▸ | FABP4 | P15090 | 2/20 | 0.38 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.38 |
| ▸ | PPARG | P37231 | 2/20 | 0.38 |
| ▸ | PPARD | Q03181 | 2/20 | 0.38 |
| ▸ | PPARA | Q07869 | 2/20 | 0.38 |
| ▸ | GMNN | O75496 | 1/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | APEX1 | P27695 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31280495 | 1.00 | FAAH (0.43) | FAAHTRPV1LPAR3TERTMAPT | |
| SCHEMBL19125743 | 1.00 | FAAH (0.43) | FAAHTRPV1LPAR3TERTMAPT | |
| SCHEMBL2802639 | 1.00 | FAAH (0.43) | FAAHTRPV1LPAR3TERTMAPT | |
| SCHEMBL16459842 | 1.00 | FAAH (0.43) | FAAHTRPV1LPAR3TERTMAPT | |
| SCHEMBL2802636 | 1.00 | FAAH (0.43) | FAAHTRPV1LPAR3TERTMAPT | |
| SCHEMBL18317965 | 1.00 | FAAH (0.43) | FAAHTRPV1LPAR3TERTMAPT | |
| SCHEMBL16459844 | 1.00 | FAAH (0.43) | FAAHTRPV1LPAR3TERTMAPT | |
| SCHEMBL3483604 | 1.00 | FAAH (0.43) | FAAHTRPV1LPAR3TERTMAPT | |
| SCHEMBL1681041 | 1.00 | FAAH (0.43) | FAAHTRPV1LPAR3TERTMAPT | |
| SCHEMBL31280307 | 1.00 | FAAH (0.43) | FAAHTRPV1LPAR3TERTMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 174 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12629657-B2 | Lithium ion adsorbents | EMPOWER INNOVATION & TECHNOLOGY LLC (US) | 2026-05-19 | — | — | US | claimed |
| EP-4223409-A1 | LITHIUM ION ADSORBENTS | Conductive Energy Inc. (CA) | 2023-08-09 | — | — | EP | claimed |
| US-20230241581-A1 | LITHIUM ION ADSORBENTS | CONDUCTIVE ENERGY INC. (CA) | 2023-08-03 | — | — | US | claimed |
| US-8815981-B2 | Hybrid organic-inorganic nanocomposites | COLUMBIA INSURANCE COMPANY (US) | 2014-08-26 | — | — | US | claimed |
| US-20130005881-A1 | Hybrid Organic-Inorganic Nanocomposites | COLUMBIA INSURANCE COMPANY | 2013-01-03 | — | — | US | claimed |
| US-8101034-B2 | Method for extending long-term electrical power cable performance | NOVINIUM, INC. (US) | 2012-01-24 | — | — | US | claimed |
| WO-2011119265-A1 | HYBRID ORGANIC-INORGANIC NANOCOMPOSITES | BENJAMIN MOORE & CO. (US) | 2011-09-29 | — | — | WO | claimed |
| US-7658808-B2 | Dielectrics; polysiloxanes | NOVINIUM, INC. (US) | 2010-02-09 | — | — | US | claimed |
| US-20090176960-A1 | METHOD FOR EXTENDING LONG-TERM ELECTRICAL POWER CABLE PERFORMANCE | NOVINIUM, INC. (US) | 2009-07-09 | — | — | US | claimed |
| EP-1938280-A2 | METHOD FOR EXTENDING LONG-TERM ELECTRICAL POWER CABLE PERFORMANCE | Novinium, Inc. (US) | 2008-07-02 | — | — | EP | claimed |
| WO-2007027826-A2 | METHOD FOR EXTENDING LONG-TERM ELECTRICAL POWER CABLE PERFORMANCE | NOVINIUM, INC. (US) | 2007-03-08 | — | — | WO | claimed |
| US-12629657-B2 | Lithium ion adsorbents | EMPOWER INNOVATION & TECHNOLOGY LLC (US) | 2026-05-19 | — | — | US | disclosed |
| EP-4590737-B1 | COMPOSITION AND ARTICLE INCLUDING A THERMOPLASTIC AND A BRANCHED SILSESQUIOXANE POLYMER AND RELATED PROCESS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2026-04-29 | — | — | EP | disclosed |
| US-12609210-B2 | Curable composition and cured body of same | TOKUYAMA CORPORATION (JP) | 2026-04-21 | — | — | US | disclosed |
| US-20260092183-A1 | SURFACE LAYER | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2026-04-02 | — | — | US | disclosed |
| EP-1373286-A2 | LINKERS AND CO-COUPLING AGENTS FOR OPTIMIZATION OF OLIGONUCLEOTIDE SYNTHESIS AND PURIFICATION ON SOLID SUPPORT | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2004-01-02 | — | — | EP | disclosed |
| US-20030120035-A1 | Linkers and co-coupling agents for optimization of oligonucleotide synthesis and purification on solid supports | THE REGENTS OF THE UNIVERSITY OF MICHIGAN | 2003-06-26 | — | — | US | disclosed |
| EP-1293522-A1 | CURABLE COMPOSITION COMPRISING PHOTOCHROMIC COMPOUND | TOKUYAMA CORPORATION (JP) | 2003-03-19 | — | — | EP | disclosed |
| US-20030036579-A1 | Curable composition comprising a photochromic compound | TOKUYAMA CORPORATION (JP) | 2003-02-20 | — | — | US | disclosed |
| WO-2002072791-A2 | LINKERS AND CO-COUPLING AGENTS FOR OPTIMIZATION OF OLIGONUCLEOTIDE SYNTHESIS AND PURIFICATION ON SOLID SUPPORT | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2002-09-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030120035-A1 | Linkers and co-coupling agents for optimization of oligonucleotide synthesis and purification on solid supports | PCNA, LIG4, DCLRE1A | FAAH 4126/4885TRPV1 4452/4885LPAR3 2935/4885 |
| US-12609210-B2 | Curable composition and cured body of same | UACA, MMAB, SMCHD1 | FAAH 2090/4885TRPV1 4803/4885LPAR3 4340/4885 |
| US-20260092183-A1 | SURFACE LAYER | EPCAM, ICAM1, ADGRE5 | FAAH 2263/4885TRPV1 945/4885LPAR3 214/4885 |
| US-20130005881-A1 | Hybrid Organic-Inorganic Nanocomposites | CAD, F2, ICAM1 | FAAH 2288/4885TRPV1 2146/4885LPAR3 3883/4885 |
| US-12629657-B2 | Lithium ion adsorbents | ILK, SDC1, LAMTOR3 | FAAH 4784/4885TRPV1 3608/4885LPAR3 2186/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.